OVERVIEW
Digital health tools — digital countermeasures — can provide an important first line of defense to augment traditional medical countermeasures in the face of health security threats. Through this program, DRIVe is seeking simple, rapidly deployable, and equitably accessible digital health tools for diagnosis and risk assessment.
PARTNERS
Companies we have partnered with on this program to date
APPROACH
Develop novel digital technologies that accelerate the response to health security threats. Proposed solutions should increase access, reduce cost, or more rapidly disseminate medical countermeasures, such as diagnosis and risk assessment capabilities, by:
- Capitalizing on broadly available and easily accessible digital platforms such as smartphones and web applications and/or
- Combining novel analytic approaches, such as AI/ML, with broadly accessible data sources such as images, audio, sensors, or user data from smartphones/wearable devices; or other novel digital data sources.
Digital health tools include smartphone, web, and telehealth applications, data sets, or algorithms that are deployable on commonly available digital devices.
Program Goals
Establish a Suite of Digital Diagnostic Tools
To provide an accelerated response to health security threats
Demonstrate Utility of Non Traditional Data Sources
To enhance our understanding of health security threats and the efficacy of MCM
Evaluate Novel Data Analytics Approaches
To offer new solutions that augment traditional medical countermeasures
DIGITAL MCMs
Previous
Amendments
1/7/22 | Revised AOI Description |
Amendment #18
10/28/22 | Revised AOI Description |
Amendment #1
1/7/22 | New Amendment | #6
1/7/22 | New Amendment | #12
1/7/22 | New Amendment | #18
Funding
Closes
10/31/24
Related Publications
CVS Health study captures emergence of SARS-CoV-2 variants
A CVS Health study conducted by its Clinical Trial Services organization under contract to the US Department of Health and Human Services provided early insights and signals...
BARDA DRIVe evolves its ENACT program into two areas of disruptive technology development of purely digital health tools...
ARDA's Division of Research, Innovation, and Ventures (DRIVE) today expanded the Early Notification to Act, Control, and Treat (ENACT) program to drive disruptive technologies needed to...
Looking for General FAQ?
Digital MCMs is open until October 31, 2024